Niccolo Pengo

Company: Mabylon

Job title: Chief Scientific Officer

Seminars:

Novel Antibodies Targeting the Inflammasome to Treat Neurodegeneration 2:30 pm

Discuss how the inflammasome is a promising target in neurodegenerative diseases Learn how Mabylon has identified novel monoclonal antibodies that hold promise for the treatment of neurodegenerationRead more

day: Day Two